Carmen Criscitiello

Broad baseline-variable profiling of visceral conversion in bone-only HR+/HER2 - metastatic breast cancer treated with CDK4/6 inhibitors.

Journal: European journal of cancer (Oxford, England : 1990)

Published: July 14, 2026

Subtype-Specific Metabolic Patterns in Staging Breast Cancer: Insights from Conventional and Parametric PET Radiomics.

Journal: Cancers

Published: May 08, 2026

Advancing breast cancer clinical management through technological innovation: the potential role of artificial intelligence and integrated care models.

Journal: ESMO open

Published: April 30, 2026

European Cancer Prevention Organization on cancer screening: an expert panel position paper.

Journal: European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP)

Published: April 29, 2026

Breast-Conserving Surgery Versus Mastectomy After Neoadjuvant Therapy: A Survival Analysis.

Journal: Annals of surgical oncology

Published: April 27, 2026

Tucatinib in patients with HER2-positive advanced/metastatic breast cancer: A systematic literature review of real-world evidence.

Journal: Breast (Edinburgh, Scotland)

Published: March 12, 2026

Analysis of Large Language Model Decision Making in Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Early Breast Cancer.

Journal: JCO clinical cancer informatics

Published: March 06, 2026

Invasive lobular and ductal breast cancers: a systematic review and metanalysis in association with BRCA1/2 mutation status.

Journal: European journal of cancer (Oxford, England : 1990)

Published: February 25, 2026

Protocol for the development and testing of a web-based patient decision aid for early-stage breast cancer patients within a cancer centre care: a mixed-method approach.

Journal: BMJ open

Published: February 24, 2026

Decluttering chemotherapy agents for HER2+early breast cancer: Do we still need carboplatin?

Journal: European journal of cancer (Oxford, England : 1990)

Published: February 20, 2026

Pan-cancer multi-omic integration of Trop2 reveals biological determinants and translational implications for ADC therapy.

Journal: NPJ precision oncology

Published: February 03, 2026

Proton therapy in breast cancer: bridging medical and radiation oncology.

Journal: Cancer treatment reviews

Published: December 30, 2025

Broad baseline-variable profiling of visceral conversion in bone-only HR+/HER2 - metastatic breast cancer treated with CDK4/6 inhibitors.

Broad baseline-variable profiling of visceral conversion in bone-only HR+/HER2 - metastatic breast cancer treated with CDK4/6 inhibitors.

Subtype-Specific Metabolic Patterns in Staging Breast Cancer: Insights from Conventional and Parametric PET Radiomics.

Subtype-Specific Metabolic Patterns in Staging Breast Cancer: Insights from Conventional and Parametric PET Radiomics.

Advancing breast cancer clinical management through technological innovation: the potential role of artificial intelligence and integrated care models.

Advancing breast cancer clinical management through technological innovation: the potential role of artificial intelligence and integrated care models.

European Cancer Prevention Organization on cancer screening: an expert panel position paper.

European Cancer Prevention Organization on cancer screening: an expert panel position paper.

Breast-Conserving Surgery Versus Mastectomy After Neoadjuvant Therapy: A Survival Analysis.

Breast-Conserving Surgery Versus Mastectomy After Neoadjuvant Therapy: A Survival Analysis.

Tucatinib in patients with HER2-positive advanced/metastatic breast cancer: A systematic literature review of real-world evidence.

Tucatinib in patients with HER2-positive advanced/metastatic breast cancer: A systematic literature review of real-world evidence.

Analysis of Large Language Model Decision Making in Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Early Breast Cancer.

Analysis of Large Language Model Decision Making in Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Early Breast Cancer.

Invasive lobular and ductal breast cancers: a systematic review and metanalysis in association with BRCA1/2 mutation status.

Invasive lobular and ductal breast cancers: a systematic review and metanalysis in association with BRCA1/2 mutation status.

Protocol for the development and testing of a web-based patient decision aid for early-stage breast cancer patients within a cancer centre care: a mixed-method approach.

Protocol for the development and testing of a web-based patient decision aid for early-stage breast cancer patients within a cancer centre care: a mixed-method approach.

Decluttering chemotherapy agents for HER2+early breast cancer: Do we still need carboplatin?

Decluttering chemotherapy agents for HER2+early breast cancer: Do we still need carboplatin?

Pan-cancer multi-omic integration of Trop2 reveals biological determinants and translational implications for ADC therapy.

Pan-cancer multi-omic integration of Trop2 reveals biological determinants and translational implications for ADC therapy.

Proton therapy in breast cancer: bridging medical and radiation oncology.

Proton therapy in breast cancer: bridging medical and radiation oncology.

Broad baseline-variable profiling of visceral conversion in bone-only HR+/HER2 - metastatic breast cancer treated with CDK4/6 inhibitors.

Broad baseline-variable profiling of visceral conversion in bone-only HR+/HER2 - metastatic breast cancer treated with CDK4/6 inhibitors.